Abstract
Androgens have been shown to affect skeletal growth, skeletal maturation, mineralization and collagen formation in animals.
This study was supported in part by U.S. Public Health Research Grant DE-02486 and in part by the National Dairy Council.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albright, F.: Cushing’s Syndrome. In: Harvey Lectures. Lancaster, Penn.: Science Press Printing Comp. 1943.
Albright, F., Reifenstein, E.C., Jr.: The Parathyroid Glands and Metabolic Bone Disease. Baltimore, Maryland: Williams & Wilkins 1948.
Almqvist, S., Ikkos, D., Luft, R.: Metabolic studies with methandrostenolone (17β-hydroxy-17α-methyl-androsta-l, 4-dien-3-one) in human subjects. Acta endocr. (Kbh.) 38, 413–418 (1961).
Armstrong, W.D., Knowlton, M., Couze, M.: Influence of estradiol and testosterone propionate on skeletal atrophy from disease and on normal bones of mature rats. Endocrinology 36, 313–322(1945).
Aschkenasy-Lelu, P., Aschkenasy, A.: Effects of androgens and oestrogens on the metabolism of proteins and the growth of tissues. In: World Review of Nutrition and Dietetics. Philadelphia: J.B. Lippincott Co. 1959.
Barker, D.J.P., Crossley, J.N.: Effect of testosterone on estrogen-induced bone formation in mice. Nature (Lond.) 194, 1088–1089 (1962).
Bavetta, L.A., Bekhor, I., Nimni, M.E.: Effects of hormone administration on collagen biosynthesis in the rat. Proc. Soc. exp. Biol. (N.Y.) 110, 294–297 (1962).
Bayley, N., Gordan, G.S., Lisser, H.: Long-term experiences with methyltestosterone as a growth stimulant in short immature boys. In: Pediatric Clinics of North America. Philadelphia: W.B. Saunders Company 1957.
Belanger, L.F., Migicovsky, B.B.: Comparative effects of vitamin D, calcium, cortisone, hydrocortisone, and norethandrolone on the epiphyseal cartilage and bone of rachitic chicks. Develop. Biol. 2, 329–342 (1960).
Belanger, L.F., Migicovsky, B.B.: Radiographic and histochemical observations on the effects of norethandrolone and calcionorethandrolone on the bones of rachitic chicks. Minerva Med. 52, 2116–2118 (1961).
Bergstrand, C.G.: The influence of testosterone propionate on skeletal development in the immature rabbit. Acta endocr. (Kbh.) 4, 91–101 (1950).
Bettmann, H.K., Goldman, H. S., Abramowicz, M., Sobel, E.H.: Oxandrolone treatment of short stature: effect of predicted mature height. J. Pediat. 79, 1018–1023 (1971).
Bohr, H.H., Dawids, S.G.: The effect of cortisone and anabolic steroids on the retention of radioactive calcium and strontium in rats. Acta endocr. (Kbh.) 47, 223–230 (1964).
Brøchner-Mortensen, K., Gerup, S., Thaysen, J.H.: The metabolic effect of new anabolic 19-nor-steroids. Acta med. scand. 165, 197–205 (1959).
Caldwell, R.A.: The effects of sex hormones in experimental osteoporosis in rats. Brit. J. exp. Path. 43, 103–115 (1962).
Castells, S.: New approaches to treatment of osteogenesis imperfecta. Clin. Orthop. 93, 239–249(1973).
Castells, S., Inamdar, S., Baker, R.K., Wallach, S.: Effects of porcine calcitonin in osteogenesis imperfecta tarda. J. Pediat. 80, 757–762 (1972).
Cattell, H.S., Clayton, B.: Failure of anabolic steroids in the therapy of osteogenesis imperfecta. J. Bone Jt. Surg. 50A, 123–141 (1968).
Clein, L.J., Kowalewski, K.: Some effects of cortisone and an anabolic steroid on healing of experimental fractures. Canad. J. Surg. 5, 108–117 (1962).
Cooke, A. M.: Osteoporosis. Lancet 268, 877–882, (1955)1.
929–937 (1955).
Dankowski, T.S., Lee, R. A., Cohn, R.E., D’Ambrosia, R.D., Limaye, N.R.: Oxandrolone therapy of growth retardation. Amer. J. Dis. Child. 109, 526–532 (1965).
Dymling, J.F., Isaksson, B., Sjorgren, B.: Anabolic steroids in the treatment of osteopenia. In: Protein Metabolism. Berlin-Heidelberg-New York: Springer 1962.
Eisenberg, E.: Effects of androgens, estrogens and corticoids on strontium kinetics in man. J. clin. Endocr. 26, 566–572 (1966).
Ershoff, B.H., Alfin-Slater, R.B., Bernick, S.: Osteoporosis in dystrophic mice. Arch. Path. 72, 599–601 (1961).
Fischer, F., Hastrup, B.: Cortisone and calcium balance (effect of calcium, vitamin D and methylandrostenediol). Acta endocr. (Kbh.) 16, 141–148 (1954).
Gardner, W.U.: Influence of sex and sex hormones on the breaking strength of bones of mice. Endocrinology 32, 149–160 (1943).
Gordan, G.S., Eisenberg, E.: The effect of estrogens, androgens and corticoids on skeletal kinetics in man. Proc. roy. Soc. Med. 56, 1027–1029 (1963).
Griboff, S.L., Herrmann, J.B., Smellin, A., Moss, J.: Hypercalcemia secondary to bone metastases from carcinoma of the breast. J. clin. Endocr. 14, 378–388 (1954).
Heaney, R.P.: Radiocalcium metabolism in disuse osteoporosis in man. Amer. J. Med. 33, 188–200(1962).
Henneman, P.H., Irwin, J.W., Wang, D.M.K., Burrage, W.S.: The effect of estrogen and androgen on calcium metabolism during cortisone administration. J. clin. Endocr. 15, 858 (1955).
Henneman, P.H., Wallach, S.: A review of prolonged use of estrogens and androgens in postmenopausal and senile osteoporosis. Arch. ntern. Med. 100, 715–723 (1957).
Hernberg, C. A.: Treatment of postmenopausal osteoporosis with oestrogens and androgens. Acta endocr. (Kbh.) 34, 51–59 (1960).
Herrmann, J. B., Kirsten, E., Krakauer, J.S.: Hypercalcemic syndrome associated with androgenic and estrogenic therapy. J. clin. Endocr. 9, 1–12 (1949).
Hollo, I.: Postmenopausal osteoporosis. Pathogenesis and the mode of action of hormone therapy. Ther. hung. 20, 123–126 (1972).
Howard, E.: Steroids and bone maturation in infant mice: relative activities of dehydroepi-androsterone and testosterone. Endocrinology 70, 131–141 (1962).
Howard, R.P., Furman, R.H.: Metabolic and serum lipid effects of methylandrostane and meth-ylandrostane pyrazoles. J. clin. Endocr. 22, 43–51 (1962).
Joss, E.E., Zuppinger, K. A., Sobel, E.H.: Effect of testosterone propionate and methyl testosterone on growth and skeletal maturation in rats. Endocrinology 72, 123–130 (1963).
Kaplan, J. G., Moshang, T., Jr., Bernstein, R., Parks, J. S., Bongiovanni, A.M.: Constitutional delay of growth and development. Effects of treatment with androgens. J. Pediat. 82, 38–44 (1973).
Keele, D.K., Vose, G.P.: A study of bone density. Amer. J. Dis. Child. 118, 759–764 (1969).
Kochakian, C.D., Murlin, J.R.: The relationship of the synthetic male hormone, androsten-dion, to the protein and energy metabolism of castrate dogs, and the protein metabolism of a normal dog. Amer. J. Physiol. 117, 642–657 (1936).
Kowalewski, K.: Comparison of the effects of cortisone and certain anabolic-androgenic steroids on the uptake of radiosulfur in a healing fractured bone. Endocrinology 62, 493–497 (1958a).
Kowalewski, K.: Uptake of radiosulphur in growing bones of cockerels treated with cortisone and 17-ethyl-19-nortestosterone. Proc. Soc. exp. Biol. (N.Y.) 97, 432–434 (1958b).
Kowalewski, K.: Uptake of radiosulfate in growing bones of cockerels treated with cortisone and certain anabolic-androgenic steroids. Endocrinology 63, 759–764 (1958c).
Kowalewski, K.: Effect of steroids on bone formation. In: Protein Metabolism. Berlin-Heidelberg-New York: Springer 1962.
Lafferty, F.W., Spencer, G.E., Pearson, O. H.: Effects of androgens, estrogens and high calcium intakes on bone formation and resorption in osteoporosis. Amer. J. Med. 36, 514–528 (1964).
Landau, R.L., Kappas, A.: Anabolic hormones in hyperparathyroidism. Ann. intern. Med. 62, 1223–1233 (1965).
Laron, Z.: Effectiveness of fluoxymesterone on linear growth and weight in children with growth retardation and underweight. Acta endocr. (Kbh.) 36, 541–548 (1961).
Laron, Z.: Use of fluoxymesterone in the treatment of growth retardation. Acta Paediat. 52, 465–472 (1963).
Laron, Z., Boss, J.H.: Failure of 19-norandrostenolonephenylpropionate (Durabolin) to prevent the alterations produced by cortisone on the growing bone in rats. Endocrinology 69, 608–612(1961).
Laron, Z., Kowadlo, A., Arie, B.Z., Kalish, L, Kende, S.: Interaction between 19 nor-andros-tenolone phenylpropionate (Durabolin) and 6-methyl-prednisolone (Medrol) on the bones of rats fed a low calcium diet. Israel J. exp. Med. 11, 41–47 (1963).
Laszlo, D., Schilling, A., Bellin, J., Gottesman, E.D., Schulman, C.A.: Effect of testosterone on patients with bone metastases. J. Amer. med. Ass. 148, 1502–1507 (1952).
Laszlo, D., Spencer, H.: Newer techniques in the study of calcium metabolism in man and effects of hormones thereon. In: Hormones and the Aging Process. New York City: Academic Press 1956.
Lederer, J.: Etude clinique d’un nouval anabolisant des proteines. Schweiz. med. Wschr. 90, 1379–1383(1960).
Levin, S.M., Simkin, A., Naor, E., Robin, G.C., Goldenberg, A., Dorfman, H.: A comparison of assay technics in experimental disuse osteoporosis: the effect of nandrolone phenylpropionate. Clin. Orthopaed. Related Res. 82, 246–252 (1972).
Lewin, I.: Metabolic effects of structurally related steroid hormones. Fed. Proc. 24, 638 (1965).
Little, K.: Interaction between catabolic and anabolic steroids. Curr. Ther. Res. 12 (10), 658–676(1970).
Llaurado, J.G., Trunnell, J.B., Claus, J.L.: Some effects of simultaneous administration of norethandrolone and cortisone in the rat. Acta endocr. (Kbh.) 32, 536–544 (1959).
MacGillivray, M.H., Kolotkin, M., Munschauer, R.W.: Enhanced linear growth responses in hypopituitary dwarfs treated with growth hormone plus androgen versus growth hormone alone. Pediat. Res. 8, 103–108 (1974).
Martin, L.G., Clark, J.W., Connor, T.B.: Growth hormone secretion enhanced by androgens. J. clin. Endocr. 28, 425–428 (1968).
McCullagh, E.P., Rossmiller, H.R.: Methyl testosterone. III. Effect upon body weight and growth. J. clin. Endocr. 1, 507–510 (1941).
McSwiney, R.R., Prunty, F.T.O.: Metabolic effects of three testosterone derivatives including 17α-ethyl-19-nortestosterone. J. Endocr. 16, 28–40 (1957).
Mellman, W.J., Bongiovanni, A.M., Garrison, M., Steikar, D.D.: Comparison of fluoxymes-terone and methyltestosterone as growth stimulants. Pediatrics 28, 525–530 (1961).
Muldowney, F.P., O’Donovan, D.K., Gallagher, J.E., Cantwell, D.F., Abrahamson, M., Freaney, R.: Bone formation in osteogenesis imperfecta: The effect of anabolic steroid therapy. J. Irish med. Ass. 54, 132–135 (1964).
Owen, M., Triffitt, J.T., Melick, R.A.: Albumin in bone. In: Hard Tissue Growth, Repair and Remineralization. Ciba Foundation Symposium 11. London: Ass. Sci. Pub. 1973.
Plum, F., Dunning, M.F.: Amelioration of hypercalciuria following poliomyelitis by 17-ethyl-19-nortestosterone (Nilevar). J. clin. Endocr. 18, 860–871 (1958).
Puche, R.C., Romano, M.C.: Effect of dehydroepiandrosterone sulfate on the mineral accretion of chick embryo frontal bones cultivated in vitro. Calc. Tis. Res. 4, 39–47 (1969).
Puche, R.C., Romano, M.G: The effect of androgens on the carbohydrate metabolism of bone. Calc. Tis. Res. 6(2), 133–142 (1970).
Raisz, L.G.: Physiologic and pharmacologic regulation of bone resorption. New Engl. J. Med. 282, 909–916(1970).
Ray, C.G., Kirschvink, J.F., Waxman, S.H., Kelley, V.G: Studies of anabolic steroids. III. The effect of oxandrolone on height and skeletal maturation in mongoloid children. Amer. J. Dis. Child. 110, 618–623(1965).
Reifenstein, E.G, Jr.: Control of corticoid-induced protein depletion and osteoporosis by anabolic steroid therapy. Metabolism 7, 78–89 (1958).
Reifenstein, E.C., Jr., Albright, F.: The metabolic effects of steroid hormones in osteoporosis. J. clin. Invest. 26, 24–56 (1947).
Reilly, W.A., Gordan, G.S.: Dissociation of growth-stimulating and skeleton-maturing actions of the synthetic androgen, fluoxymesterone. J. Pediat. 59, 188–193 (1961).
Riggs, B.L., Jowsey, J., Kelly, P. J., Jones, J. D., Maher, F.T.: Effect of sex hormones on bone in primary osteoporosis. J. clin. Invest. 48, 1065–1072 (1969).
Riggs, B.L., Ryan, R.J., Wahner, H.W., Jiang, N.-S., Mattox, V.R.: Serum concentrations of estrogen, testosterone and gonadotropins in osteoporotic and nonosteoporotic postmenopausal women. J. clin. Endocr. 36, 1097–1099 (1973).
Robison, R.: Possible significance of hexosephosphoric esters in ossification. Biochem. J. 17, 286–293 (1923).
Rodin, A.E., Kowalewski, K.: Histological and histochemical effects of cortisone and an anabolic androgen on long bones of young cockerels and rats. Canad. J. Surg. 6, 229–236 (1963).
Running, O., Makinen, E., Lahtinen, K., Faijola, E.: Effect of nandrolone phenylpropionate on the bone of young rats. Endocrinology 75, 477–484 (1964).
Ropes, M.W., Rossmeisl, E.C., Bauer, W.: The effect of estrin in osteogenesis imperfecta. J. clin. Invest. 25, 932–933(1946).
Rubinstein, H.S., Solomon, M.L.: The growth depressing effect of large doses of testosterone propionate in the castrate albino rat. Endocrinology 28, 112–114 (1941).
Scharer, V.K., Habich, H., Prader, A.: Wachstumsförderung mit neuen anabolen Steroiden. Helv. med. Acta 27, 530–534 (1960).
Schilling, A., Laszlo, D.: Rate of urinary calcium excretion following intravenous administration as an indicator of bone metabolism. Proc. Soc. exp. Biol. (N.Y.) 78, 286–289 (1951).
Silberberg, M., Silberberg, R.: Response of cartilage and bone of growing mice to testosterone propionate. Arch. Path. 32, 85–95 (1941).
Silberberg, M., Silberberg, R.: Steroid hormones and bone. In: The Biochemistry and Physiology of Bone. New York City: Academic Press 1956.
Simpson, M.E., Marx, W., Becks, H., Evans, H.M.: Effect of testosterone propionate on the body weight and skeletal system of hypophysectomized rats. Synergism with pituitary growth hormone. Endocrinology 35, 309–316 (1944).
Skoog, W. A., Adams, W. S.: Metabolic balance studies of a patient with multiple myeloma given combined ACTH-androgen therapy: Comparisons of three androgens administered in varying dosage on exchanges of calcium, phosphorus and nitrogen. Metabolism 2, 614–625 (1962).
Smith, Q. T., Allison, D.J.: Cutaneous collagen and hexosamine and femur collagen of testosterone propionate-treated rats of various ages. Biochem. Pharmacol. 14, 709–720 (1965).
Sobel, H., Bonorris, G.: Effect of hormones on femurs and carcass nitrogen of animals treated with antianabolic agents. Metabolism 12, 246–251 (1963).
Sobel, E.H., Raymond, S., Quinn, K.V., Talbot, N.B.: The use of methyltestosterone to stimulate growth: Relative influence on skeletal maturation and linear growth. J. clin. Endocr. 16, 241–248 (1956).
Solomons, C.C., Styner, J.: Osteogenesis imperfecta: Effect of magnesium administration on pyrophosphate metabolism. Calc. Tis. Res. 3, 318–326 (1969).
Spencer, H.: unpublished data.
Spencer, H., Berger, E., Charles, M. L., Gottesman, E.D., Laszlo, D.: Metabolic effects of 17-ethyl-19-nortestosterone in man. J. clin. Endocr. 17, 975–984 (1957).
Spencer, H., Hausinger, A., Laszlo, D.: The calcium tolerance test in senile osteoporosis. J. Amer. Geriat. 2, 19–25 (1954).
Spencer, H., Lewin, I.: Derangements of calcium metabolism in patients with neoplastic bone involvement. J. chron. Dis. 16, 713–726 (1963).
Spencer, H., Lewin, L, Friedland, J.A.: Changes in calcium metabolism in metastatic bone disease. Israel J. med. Sci. 3, 643–656 (1967).
Spencer, H., Menczel, J., Lewin, I.: Metabolie and radioisotope studies in osteoporosis. Clin. Orthopaed. 35, 202–219 (1964a).
Spencer, H., Menczel J., Lewin, I., Samachson, J.: Absorption of calcium in osteoporosis. Amer. J. Med. 37, 223–234 (1964 b).
Stern, P.H.: Inhibition by steroids of parathyroid hormone-induced Ca45 release from embryonic rat bone in vitro. J. Pharmacol. exp. Ther. 168, 211–217 (1969).
Swyer, A.J., Berger, J.S., Gordon, H.M., Laszlo, D.: Hypercalcemia in osteolytic metastatic cancer of the breast. Amer. J. Med. 8, 724–732 (1950).
Tanabe, Y., Wilcox, F.H.: Endocrine control of serum alkaline phosphatase activity in the chicken. Poultry Sci. 49, 411–416 (1961).
Tyslowitz, R.F.: Trans. 4th Josiah Macy, Jr. Conf. on Metabolic Aspects Convalescence, p. 123, 1943.
Urist, M.R., Budy, A.M., McLean, F.C.: Endosteal-bone formation in estrogen-treated mice. Amer. J. Bone Jt. Surg. 32, 143–162 (1950).
Van Wayjen, R.G.A.: Long term balance studies on certain anabolic agents. Symposium on Anabolic Therapy, Michigan and Wayne County Academies of General Practice, Detroit, Michigan, March 21, 1962.
Van Wayjen, R.G.A., Buyze, G.: Clinical-pharmacological evaluation of certain anabolic steroids. Acta endocr. (Kbh.) (Suppl. 63) 39, 18–36 (1961).
Vittek, J., Altman, K., Gordon, G.G., Southren, A.L.: The metabolism of 7α-3H-testosterone by rat mandibular bone. Endocrinology 94, 325–329 (1974).
Vose, G. P., Keele, D. K.: Bone growth in nonambulatory children on oxymetholone and fluoride therapies. Growth 37, 213–221 (1973).
Watkin, D.M.: The assessment of protein nutrition in aged man. Ann. N.Y. Acad. Sci. 69, 902–913(1958).
Watkin, D.M., Parsons, J.M., Yiengst, M.J., Shock, N.W.: Metabolism in the aged: The effect of stanolone on the retention of nitrogen, potassium, phosphorus, and calcium and on the urinary excretion of 17-keto, 11-oxy, and 17-hydroxy steroids in eight elderly men on high and low protein diets. J. Gerontol. 10, 268–287 (1955).
Wentworth, J.H., Smith, P.K., Gardner, W.U.: The composition of bones of mice receiving estrogens and androgens. Endocrinology 26, 61–67 (1940).
Whedon, G.D., Shorr, E.: Metabolic studies in paralytic acute anterior poliomyelitis. J. clin. Invest. 36, 941–1033(1957).
Wiancko, K.B., Kowalewski, K.: Strength of callus in fractured humerus of rat treated with anti-anabolic and anabolic compounds. Acta Endocr. (Kbh.) 36, 310–318 (1961).
Wilkins, L.: Disturbances in growth. Bull. N.Y. Acad. Med. 29, 280–294 (1953).
Woodard, H.Q.: Changes in blood chemistry associated with carcinoma metastatic to bone. Cancer 6, 1219–1227(1953).
Woodard, H.Q., Escher, G.C., Farrow, J.H.: Changes in the blood chemistry of patients with disseminated carcinoma of the breast during endocrine therapy. Cancer 7, 744–757 (1954).
Zachmann, M., Prader, A.: Anabolic and androgenic effect of testosterone in sexually immature boys and its dependency on growth hormone. J. clin. Endocr. 30, 85–95 (1970).
Zanganah, F., Steiner, M.M.: Oxandrolone therapy in growth retardation of children. Amer. J. Dis. Child. 113, 233–241 (1967).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Spencer, H., Friedland, J.A., Lewin, I. (1976). Effect of Androgens on Bone, Calcium, and Phosphorus Metabolism. In: Kochakian, C.D. (eds) Anabolic-Androgenic Steroids. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 43. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66353-6_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-66353-6_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66355-0
Online ISBN: 978-3-642-66353-6
eBook Packages: Springer Book Archive